权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Dynamic changes of the Nav1.5 interactome and contributions to heart failure

Nav1.5 相互作用组的动态变化及其对心力衰竭的影响

基本信息

批准号：
10317712
负责人：
Steven O Marx
金额：
$ 69.7万
依托单位：
WEILL MEDICAL COLL OF CORNELL UNIV
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-09-01 至 2025-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10317712
关键词：
ANK3 gene Ablation Action Potentials Affect Anterior Arrhythmia Arteries Binding Biotin Brugada syndrome Cardiac Cardiac Myocytes Cardiomyopathies Chronic Complex Congestive Heart Failure Coupled Development Dilated Cardiomyopathy Disease Fibroblast Growth Factor Functional disorder Generations Goals Heart failure In Situ Individual Infusion procedures Inherited Intercalated disc Investigation Ion Channel Isoproterenol Knock-out Label Lateral Left Life Ligase Ligation Long QT Syndrome Macromolecular Complexes Maps Mass Spectrum Analysis Membrane Modeling Multiprotein Complexes Mus Mutation Neighborhoods Pathologic Peroxidases Phosphoproteins Physiological Property Proteins Proteomics Records Regulation Risk Role Signal Transduction Sodium Channel Specificity Validation ascorbate candidate validation cohort constriction defined contribution design fibroblast growth factor 13 innovation insight junctophilin knock-down member mouse model mutant novel novel strategies overexpression pressure protective effect sodium channel proteins tool voltage

项目摘要

The NaV1.5 voltage-gated Na+ channel encoded by SCN5A is the fundamental component of macromolecular protein complexes that initiate the cardiac action potential. Abnormal NaV1.5 function is a prominent substrate for inherited and acquired forms of cardiac arrhythmias, reflected by a staggering array of identified NaV1.5 mutations. A small subset of these are associated with dilated cardiomyopathy but the underlying mechanisms are not known. A leading hypothesis, that the arrhythmias drive the cardiomyopathy, cannot explain why most arrhythmogenic NaV1.5 mutations do not cause cardiomyopathy nor why knockout of the NaV1.5 interacting protein FGF13 leads to arrhythmias yet is protective for pressure overload-induced heart failure (HF) despite associated NaV1.5 dysfunction. Moreover, HF from other causes leads to pathological remodeling that disrupts regulation of the VGSC macromolecular complex and increases arrhythmia risk through mechanisms that are poorly understood. Complicating mechanistic insight is that there are different NaV1.5 pools defined by distinct subcellular localizations with the cardiomyocyte, each hypothesized to have protein partners that uniquely define the distinct pools and confer specific channel properties and functions. However, the critical partners remain poorly understood because of challenges of low throughput “favorite” candidate approaches. We propose an unbiased multilevel discovery strategy, employing newly developed second generation proximity labeling tools, novel mouse models, coupled with carefully calibrated cross comparisons designed to increase the specificity of our findings. Exploiting the expertise from two labs with individual and collaborative track records applying a large tool set to dissect complex physiologic mechanisms and define perturbations in pathological states, we propose adaptable candidate validation approaches to establish a comprehensive picture of NaV1.5 interactomes under physiological states and when perturbed by disease. With these innovative approaches we propose to: 1) Define the static and dynamic NaV1.5 channel interactomes and “neighborhoods” within distinct subcellular pools; 2) Elucidate how HF alters the NaV1.5 microenvironment; and 3) Determine the HF-protective effects for ablation of the NaV1.5 interactor, FGF13. With these aims, our goals are to define the contributions of the NaV1.5 macromolecular to development and progression of HF and its associated arrhythmias and to unravel how HF perturbs the NaV1.5 complex to increase arrhythmia risk and exacerbate HF in a vicious cycle.

由SCN5A编码的NaV1.5电压门控Na+通道是